Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BIO-006 P. vivax controlled human malaria infection relapse study
NL-OMON57368Completed
- Sponsor
- University of Oxford
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of primaquine in malaria and vivax malaria, sponsored by University of Oxford. Primary endpoints: Safety of primary and relapsing P. vivax infection following sporozoite-administered CHMI, Primary P. vivax infection after sporozoite-administered CHMI and 1 more. Started Apr 2025; status: completed.
02
Drugs
primaquine
03
Conditions
malariavivax malaria
Beyond the preview
Go deeper on NL-OMON57368.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON57368.